View in EDS HTML Full Text PDF Full Text

Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.

Saved in:
Bibliographic Details
Title: Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.
Authors: Sarkozy C; Hematology Departement, Institut Curie, Saint Cloud, Université de Versailles Saint-Quentin (UVSQ), Versailles, France., Chartier L; Statistiques, Lymphoma Academic Research Organisation (LYSA), Piérre-Benite, France., Ribrag V; Haematology Department, Institut Gustave Roussy, Villejuif, France., Gressin R; Haematology Department, Univ. Grenoble Alpes. University Hospital, Grenoble France & Institute For Advanced Biosciences (INSERM U1209), Grenoble, France., Geisler CH; Haematology Department, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark., Kluin-Nelemans HC; Haematology Department, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Thieblemont C; Université Paris Cité, Inserm U1153, Paris, France.; Hemato-oncology Department, Hôpital Saint Louis, Assistance Publique - Hôpitaux de Paris, Paris, France., Morschhauser F; Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France., Lemonnier F; Haematology Department, Groupe Hospitalier Mondor, Assistance Publique Hôpitaux de Paris, Paris, France., Safar V; Haematology Department, Centre hospitalier Lyon Sud - 145 Chemin du Grand Revoyet, Pierre Bénite, France., Tessoulin B; Haematology Department, Nantes University Hospital, Nantes, France., Oberic L; Haematology Department, Institut universitaire du cancer Toulouse- Oncopole, Toulouse, France., Damaj G; Haematology Department, Normandie University, Hematology Institute, Caen, France., Ghesquières H; Haematology Department, Centre hospitalier Lyon Sud - 145 Chemin du Grand Revoyet, Pierre Bénite, France., Bouabdallah K; Haematology Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France., Casasnovas RO; Haematology Department, Centre Hospitalier Universitaire Dijon, INSERM UMR1231, Dijon, France., Houot R; Department of Hematology, University Hospital of Rennes, UMR U1236, INSERM, University of Rennes, French Blood Establishment, Rennes, France., Klapper W; Institut für Pathologie, Sektion Hämatopathologie und Lymphknotenregister, University Hospital Schleswig-Holstein Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany., Burroni B; Department of Pathology, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Pott C; University Hospital Schleswig-Holstein Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany., Delfau-Larue MH; Biological Haematology and Immunology Department, Groupe Hospitalier Mondor, Assistance Publique Hôpitaux de Paris, INSERM U955, Paris, France., Macintyre E; Biological Haematology Department, Necker-Enfants malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France., Callanan M; University of Burgundy-INSERM 1231-CHU Dijon, DIJON, France., Jerkeman M; Department of Oncology, Institute of Clinical Sciences, Lund University and Skane University Hospital SE22185, Lund, Sweden., Unterhalt M; Department of Medicine III, LMU University Hospital, Munich, Germany., Hoster E; Institute for Medical Information Processing, Biometry, and Epidemiology, LMU Munich, Munich, Germany., Dreyling M; Department of Medicine III, LMU University Hospital, Munich, Germany., Le Gouill S; Hematology Departement, Institut Curie, Saint Cloud, Université de Versailles Saint-Quentin (UVSQ), Versailles, France., Hermine O; Haematology Department, Necker-Enfants malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Université Paris Cité, Institut Imagine, Laboratory of Hematological Disorders, INSERM UMR1163, Paris, France., Cheminant M; Haematology Department, Necker-Enfants malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. morgane.cheminant@aphp.fr.; Université Paris Cité, Institut Imagine, Laboratory of Hematological Disorders, INSERM UMR1163, Paris, France. morgane.cheminant@aphp.fr.
Source: Blood cancer journal [Blood Cancer J] 2025 Apr 24; Vol. 15 (1), pp. 78. Date of Electronic Publication: 2025 Apr 24.
Publication Type: Journal Article; Validation Study
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40274771
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sarkozy+C%22">Sarkozy C</searchLink>; Hematology Departement, Institut Curie, Saint Cloud, Université de Versailles Saint-Quentin (UVSQ), Versailles, France.<br /><searchLink fieldCode="AU" term="%22Chartier+L%22">Chartier L</searchLink>; Statistiques, Lymphoma Academic Research Organisation (LYSA), Piérre-Benite, France.<br /><searchLink fieldCode="AU" term="%22Ribrag+V%22">Ribrag V</searchLink>; Haematology Department, Institut Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Gressin+R%22">Gressin R</searchLink>; Haematology Department, Univ. Grenoble Alpes. University Hospital, Grenoble France & Institute For Advanced Biosciences (INSERM U1209), Grenoble, France.<br /><searchLink fieldCode="AU" term="%22Geisler+CH%22">Geisler CH</searchLink>; Haematology Department, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Kluin-Nelemans+HC%22">Kluin-Nelemans HC</searchLink>; Haematology Department, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Thieblemont+C%22">Thieblemont C</searchLink>; Université Paris Cité, Inserm U1153, Paris, France.; Hemato-oncology Department, Hôpital Saint Louis, Assistance Publique - Hôpitaux de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Morschhauser+F%22">Morschhauser F</searchLink>; Univ. Lille, CHU Lille, ULR 7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.<br /><searchLink fieldCode="AU" term="%22Lemonnier+F%22">Lemonnier F</searchLink>; Haematology Department, Groupe Hospitalier Mondor, Assistance Publique Hôpitaux de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Safar+V%22">Safar V</searchLink>; Haematology Department, Centre hospitalier Lyon Sud - 145 Chemin du Grand Revoyet, Pierre Bénite, France.<br /><searchLink fieldCode="AU" term="%22Tessoulin+B%22">Tessoulin B</searchLink>; Haematology Department, Nantes University Hospital, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Oberic+L%22">Oberic L</searchLink>; Haematology Department, Institut universitaire du cancer Toulouse- Oncopole, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Damaj+G%22">Damaj G</searchLink>; Haematology Department, Normandie University, Hematology Institute, Caen, France.<br /><searchLink fieldCode="AU" term="%22Ghesquières+H%22">Ghesquières H</searchLink>; Haematology Department, Centre hospitalier Lyon Sud - 145 Chemin du Grand Revoyet, Pierre Bénite, France.<br /><searchLink fieldCode="AU" term="%22Bouabdallah+K%22">Bouabdallah K</searchLink>; Haematology Department, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Casasnovas+RO%22">Casasnovas RO</searchLink>; Haematology Department, Centre Hospitalier Universitaire Dijon, INSERM UMR1231, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Houot+R%22">Houot R</searchLink>; Department of Hematology, University Hospital of Rennes, UMR U1236, INSERM, University of Rennes, French Blood Establishment, Rennes, France.<br /><searchLink fieldCode="AU" term="%22Klapper+W%22">Klapper W</searchLink>; Institut für Pathologie, Sektion Hämatopathologie und Lymphknotenregister, University Hospital Schleswig-Holstein Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Burroni+B%22">Burroni B</searchLink>; Department of Pathology, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Pott+C%22">Pott C</searchLink>; University Hospital Schleswig-Holstein Campus Kiel/Christian-Albrechts University Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Delfau-Larue+MH%22">Delfau-Larue MH</searchLink>; Biological Haematology and Immunology Department, Groupe Hospitalier Mondor, Assistance Publique Hôpitaux de Paris, INSERM U955, Paris, France.<br /><searchLink fieldCode="AU" term="%22Macintyre+E%22">Macintyre E</searchLink>; Biological Haematology Department, Necker-Enfants malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.<br /><searchLink fieldCode="AU" term="%22Callanan+M%22">Callanan M</searchLink>; University of Burgundy-INSERM 1231-CHU Dijon, DIJON, France.<br /><searchLink fieldCode="AU" term="%22Jerkeman+M%22">Jerkeman M</searchLink>; Department of Oncology, Institute of Clinical Sciences, Lund University and Skane University Hospital SE22185, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Unterhalt+M%22">Unterhalt M</searchLink>; Department of Medicine III, LMU University Hospital, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Hoster+E%22">Hoster E</searchLink>; Institute for Medical Information Processing, Biometry, and Epidemiology, LMU Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Dreyling+M%22">Dreyling M</searchLink>; Department of Medicine III, LMU University Hospital, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Le+Gouill+S%22">Le Gouill S</searchLink>; Hematology Departement, Institut Curie, Saint Cloud, Université de Versailles Saint-Quentin (UVSQ), Versailles, France.<br /><searchLink fieldCode="AU" term="%22Hermine+O%22">Hermine O</searchLink>; Haematology Department, Necker-Enfants malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.; Université Paris Cité, Institut Imagine, Laboratory of Hematological Disorders, INSERM UMR1163, Paris, France.<br /><searchLink fieldCode="AU" term="%22Cheminant+M%22">Cheminant M</searchLink>; Haematology Department, Necker-Enfants malades University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. morgane.cheminant@aphp.fr.; Université Paris Cité, Institut Imagine, Laboratory of Hematological Disorders, INSERM UMR1163, Paris, France. morgane.cheminant@aphp.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2025 Apr 24; Vol. 15 (1), pp. 78. <i>Date of Electronic Publication: </i>2025 Apr 24.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Validation Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40274771
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-025-01241-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 78
    Titles:
      – TitleFull: Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sarkozy C
      – PersonEntity:
          Name:
            NameFull: Chartier L
      – PersonEntity:
          Name:
            NameFull: Ribrag V
      – PersonEntity:
          Name:
            NameFull: Gressin R
      – PersonEntity:
          Name:
            NameFull: Geisler CH
      – PersonEntity:
          Name:
            NameFull: Kluin-Nelemans HC
      – PersonEntity:
          Name:
            NameFull: Thieblemont C
      – PersonEntity:
          Name:
            NameFull: Morschhauser F
      – PersonEntity:
          Name:
            NameFull: Lemonnier F
      – PersonEntity:
          Name:
            NameFull: Safar V
      – PersonEntity:
          Name:
            NameFull: Tessoulin B
      – PersonEntity:
          Name:
            NameFull: Oberic L
      – PersonEntity:
          Name:
            NameFull: Damaj G
      – PersonEntity:
          Name:
            NameFull: Ghesquières H
      – PersonEntity:
          Name:
            NameFull: Bouabdallah K
      – PersonEntity:
          Name:
            NameFull: Casasnovas RO
      – PersonEntity:
          Name:
            NameFull: Houot R
      – PersonEntity:
          Name:
            NameFull: Klapper W
      – PersonEntity:
          Name:
            NameFull: Burroni B
      – PersonEntity:
          Name:
            NameFull: Pott C
      – PersonEntity:
          Name:
            NameFull: Delfau-Larue MH
      – PersonEntity:
          Name:
            NameFull: Macintyre E
      – PersonEntity:
          Name:
            NameFull: Callanan M
      – PersonEntity:
          Name:
            NameFull: Jerkeman M
      – PersonEntity:
          Name:
            NameFull: Unterhalt M
      – PersonEntity:
          Name:
            NameFull: Hoster E
      – PersonEntity:
          Name:
            NameFull: Dreyling M
      – PersonEntity:
          Name:
            NameFull: Le Gouill S
      – PersonEntity:
          Name:
            NameFull: Hermine O
      – PersonEntity:
          Name:
            NameFull: Cheminant M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 04
              Text: 2025 Apr 24
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1